Glucose Intolerance and Diabetes Mellitus in Endocrine Disorders - Two Case Reports and a Review

被引:9
作者
Adlan, M. A. [1 ]
Bondugulapati, L. N. R. [1 ]
Premawardhana, L. D. K. E. [1 ]
机构
[1] Caerphilly Miners Hosp, Dept Med, Sect Diabet & Endocrinol, Caerphilly CF83 2WW, Wales
关键词
Endocrinopathy; Diabetes mellitus; Insulin resistance;
D O I
10.2174/157339910793360860
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Impaired glucose tolerance and diabetes mellitus are a manifestation of several well recognised endocrine disorders. Hyperglycaemia subsides upon removal of the underlying cause in these conditions - usually a hormone secreting tumour. We describe two subjects who were cured of their poorly controlled diabetes mellitus following surgical removal of a phaeochromocytoma and a cortisol secreting adrenal adenoma and review the mechanisms underlying glucose intolerance in endocrine disorders. The reported incidence of diabetes is variable in these conditions and may range between 295%. The severity is also variable as some affected individuals have only minor glucose intolerance while others have frank symptomatic diabetes mellitus which forms a major manifestation of their illness. The mechanisms causing hyperglycaemia are (a) insulin resistance, (b) increased hepatic glucose production and output, (c) decreased insulin production and release and (d) increased intestinal glucose absorption. Multiple intermediate mechanisms which include electrolyte perturbations and hormone receptor and post receptor mediated effects are responsible for these abnormalities. An understsanding of these mechanisms and diagnostic strategies is important as these may be used to advantage in managing these patients. We describe some of these in greater detail below.
引用
收藏
页码:266 / 273
页数:8
相关论文
共 84 条
[1]   Metformin and the intestine [J].
Bailey, C. J. ;
Wilcock, C. ;
Scarpello, J. H. B. .
DIABETOLOGIA, 2008, 51 (08) :1552-1553
[2]  
Baxter JD, 1979, GLUCOCORTICOID HORMO, P25
[3]   beta-cell function and glucose and lipid oxidation in Graves' disease [J].
Bech, K ;
Damsbo, P ;
Eldrup, E ;
BeckNielsen, H ;
Roder, ME ;
Hartling, SG ;
Volund, A ;
Madsbad, S .
CLINICAL ENDOCRINOLOGY, 1996, 44 (01) :59-66
[4]  
Biering H, 2000, ACTA MED AUST, V27, P27, DOI 10.1046/j.1563-2571.2000.00106.x
[5]  
BLOOM SR, 1973, LANCET, V2, P14
[6]  
Bloom SR, 1982, AM J MED S B, V5B, P25
[7]  
Bravo EL, 1984, NEW ENGL J MED, V311, P1303
[8]  
BROWN MJ, 1981, LANCET, V1, P174
[9]   APUDOMAS AND DIABETES-MELLITUS [J].
BUCHANAN, KD .
BAILLIERES CLINICAL ENDOCRINOLOGY AND METABOLISM, 1992, 6 (04) :899-909
[10]   Immunomodulatory role of prolactin in diabetes development [J].
Cejkova, P. ;
Fojtikova, M. ;
Cerna, M. .
AUTOIMMUNITY REVIEWS, 2009, 9 (01) :23-27